Skip to Content

Juvisync

In the US, Juvisync (simvastatin/sitagliptin systemic) is a member of the following drug classes: antidiabetic combinations, antihyperlipidemic combinations and is used to treat Cardiovascular Risk Reduction, Diabetes - Type 2, High Cholesterol, High Cholesterol - Familial Heterozygous and High Cholesterol - Familial Homozygous.

US matches:

Ingredient matches for Juvisync

Simvastatin

Simvastatin is reported as an ingredient of Juvisync in the following countries:

  • United States

Sitagliptin

Sitagliptin is reported as an ingredient of Juvisync in the following countries:

  • United States

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide